SEC Form 4 · accession 0001209191-15-052528
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
L. Patrick Giroir Jr.
Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 8:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $42.26 | Jun 10, 2015 | A | 10,000 | A | — | Jun 9, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Vests in equal quarterly installments over a one-year period measured from the date of grant.